Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

SomaLogic, Inc. (SLGC)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.18-0.19 (-3.54%)
At close: 04:00PM EDT
5.11 -0.07 (-1.35%)
After hours: 05:20PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close5.37
Open5.41
Bid4.50 x 1800
Ask5.40 x 3100
Day's Range5.10 - 5.45
52 Week Range4.20 - 14.72
Volume18,445,499
Avg. Volume1,721,637
Market Cap938.476M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.40
Earnings DateNov 15, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.00
  • Simply Wall St.

    What Type Of Shareholders Own The Most Number of SomaLogic, Inc. (NASDAQ:SLGC) Shares?

    The big shareholder groups in SomaLogic, Inc. ( NASDAQ:SLGC ) have power over the company. Large companies usually have...

  • GlobeNewswire

    SomaLogic Announces License Agreement with OncoHost for the Development of Precision Cancer Diagnostics

    BOULDER, Colo. and BINYAMINA, Israel, June 13, 2022 (GLOBE NEWSWIRE) -- SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced it has signed a licensing agreement with OncoHost, a global leader in next-generation precision oncology for personalized cancer therapy. As part of the agreement, OncoHost will license SomaLogic’s SomaScan® Platform to develop proteomics tests for its PROphet® diagnostic system, designed to predict patient response to immunotherapy trea

  • GlobeNewswire

    SomaLogic Announces June Conference Participation

    BOULDER, Colo., June 01, 2022 (GLOBE NEWSWIRE) -- SomaLogic, Inc., a leader in AI-data driven proteomics technology, today announced that the company will be participating in the following conferences. Jefferies Healthcare ConferenceJune 8-9, 2022, in New York 7th Annual MarketsandMarkets Biomarker and Companion Diagnostics ConferenceJoe Gogain, Director, Clinical R&D will present “Bigger data = better data. Detect 7,000 proteins at once with high throughput to optimize biomarker discover” durin

Advertisement
Advertisement